IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Actavis to acquire Warner Chilcott in deal worth up to $8.5 billion

2:52 AM MDT | May 21, 2013 | Francinia Protti-Alvarez

Actavis (Parsippany, NJ) and Warner Chilcott (Dublin) have entered into a definitive agreement under which Actavis will acquire Warner Chilcott in a stock-for-stock transaction valued at approximately $5 billion, or $8.5 billion including net debt, the companies have announced. The deal represents a 43% premium compared with Warner Chilcott's volume-weighted average trading price of $14.00 for the 30-day trading period ended 9 May—the day before Warner Chilcott disclosed it was engaged in preliminary discussions with Actavis—and a 34% premium to the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa